Cell Therapy Collaboration Program News Today

Thermo Fisher Scientific, the world leader in serving science, and Arsenal Biosciences, Inc. (ArsenalBio), a clinical-stage cell therapy company engineering advanced chimeric antigen receptor (CAR)-T cell therapies for solid tumors, today announced an update to our strategic collaboration to further the development of manufacturing processes for new cancer treatments.

Program supports cell therapy innovators in the development of next-generation, life-saving drugs and therapeutics through every stage of their journey to improve patient outcomes SINGAPORE, Feb. 7, 2023 /PRNewswire/ --Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of its new Cell Therapy Collaboration Center Program in Singapore to accelerate cell therapy development across the Asia Pacific region. The center, based in Singapore, will serve as the...